Filtros : "CARDIOLOGIA" "FARMACOLOGIA" "EEFE" Removidos: "ACIDENTE VASCULAR CEREBRAL" "BARBANTI, VALDIR JOSE" "MASSA, MARCELO" "Finlândia" "Marrocos" "Circulation" Limpar

Filtros



Refine with date range


  • Source: Journal of Molecular and Cellular Cardiology. Unidade: EEFE

    Subjects: FARMACOLOGIA, FISIOLOGIA, INSUFICIÊNCIA CARDÍACA, CARDIOLOGIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Julio Cesar Batista e BRUM, Patricia Chakur e MOCHLY-ROSEN, Daria. 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, v. 51, p. 479-484, 2011Tradução . . Disponível em: http://ac.els-cdn.com/S0022282810003998/1-s2.0-S0022282810003998-main.pdf?_tid=3405d86058fa5d8193f1f43cdbe58326&acdnat=1342119331_155a76a1dea8dac900622cc4ec7fbc0e. Acesso em: 15 out. 2024.
    • APA

      Ferreira, J. C. B., Brum, P. C., & Mochly-Rosen, D. (2011). 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, 51, 479-484. doi:10.1016/j.yjmcc.2010.10.020
    • NLM

      Ferreira JCB, Brum PC, Mochly-Rosen D. 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 479-484.[citado 2024 out. 15 ] Available from: http://ac.els-cdn.com/S0022282810003998/1-s2.0-S0022282810003998-main.pdf?_tid=3405d86058fa5d8193f1f43cdbe58326&acdnat=1342119331_155a76a1dea8dac900622cc4ec7fbc0e
    • Vancouver

      Ferreira JCB, Brum PC, Mochly-Rosen D. 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 479-484.[citado 2024 out. 15 ] Available from: http://ac.els-cdn.com/S0022282810003998/1-s2.0-S0022282810003998-main.pdf?_tid=3405d86058fa5d8193f1f43cdbe58326&acdnat=1342119331_155a76a1dea8dac900622cc4ec7fbc0e
  • Source: Journal of Molecular and Cellular Cardiology. Unidade: EEFE

    Subjects: FARMACOLOGIA, HIPERTENSÃO, INSUFICIÊNCIA CARDÍACA, CARDIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Julio Cesar Batista et al. Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy. Journal of Molecular and Cellular Cardiology, v. 51, p. 980-987, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.yjmcc.2011.08.025. Acesso em: 15 out. 2024.
    • APA

      Ferreira, J. C. B., Koyanagi, T., Palaniyandi, S. S., Fajardo, G., Brum, P. C., & Mochly-Rosen, D. (2011). Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy. Journal of Molecular and Cellular Cardiology, 51, 980-987. doi:10.1016/j.yjmcc.2011.08.025
    • NLM

      Ferreira JCB, Koyanagi T, Palaniyandi SS, Fajardo G, Brum PC, Mochly-Rosen D. Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 980-987.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.yjmcc.2011.08.025
    • Vancouver

      Ferreira JCB, Koyanagi T, Palaniyandi SS, Fajardo G, Brum PC, Mochly-Rosen D. Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 980-987.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.yjmcc.2011.08.025

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024